Pharmacist-Intensivist Collaborative Telehealth for Post-Intensive Care Syndrome in Survivors of Critical Illness: a Pilot Randomized Controlled Trial
Malcom Randall VA Medical Center
Summary
The goal of this pilot randomized controlled trial is to determine if a randomized controlled trial of a collaborative pharmacist-intensivist telehealth follow-up after intensive care unit discharge can feasibly be performed in patients who have survived a critical illness. The study intervention will be telehealth follow-up appointments provided by clinical pharmacists at approximately one and three months post-hospital discharge. The purpose of the follow-up appointments will be to assess for post-intensive care syndrome and provide recommend interventions aimed at improving recovery Participants will randomized to receive the study intervention or standard of care.
Eligibility
- Age range
- 18–89 years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Adults 18-89 years of age * Required admission to either medical or surgical ICU * Respiratory failure requiring invasive mechanical ventilation of at least 24 hours during ICU stay; or ICU stay of at least 7 days * Anticipated discharge to home after hospitalization * Consent from patients themselves or a legally authorized representative if necessary Exclusion Criteria: * Pregnancy * Incarceration/Imprisonment * Life expectancy less than 6 months or enrolled in hospice/palliative care * Anticipated discharge to skilled nursing facility, medical rehabilitation facilit…
Interventions
- BehavioralPost-ICU Telehealth Follow-up
The post-ICU clinic follow-up will be conducted by a pharmacist via a telehealth visit. A collaborating physician (i.e. intensivist) will provide clinical support and oversight as needed. The appointments will be 30-60 minute telephone/video calls. Participants be assessed for PICS and recommended interventions to improve their care.
Location
- Malcom Randall Veterans Affairs Medical CenterGainesville, Florida